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Abstract~alcitriol-induced differentiation of U937 mononuclear phagocytes is known to have divergent 
effects on the synthesis of urokinase-type plasminogen activator (uPA) and plasminogen activator 
inhibitor-2 (PAI-2). In this study, we sought to determine whether calcitriol affects the expression of 
these proteins by modulating intermediate signal trasduction involving intracellular calcium and protein 
kinase C (PKC). U937 cells were stimulated with calcitriol (50 nM) for 6-72 hr, inducing a transient 
increase in specific binding of [3H]phorbol dibutyrate ([3H]PDBu), seen only after 24 hr. Staurosporine 
(2 nM), a PKC inhibitor, had no effect on calcitriol-induced secretion of plasminogen activator (PA) 
activity. However, staurosporine significantly (P < 0.05) inhibited the ability of calcitriol to enhance 
phorbol myristate acetate (PMA)-induced secretion of PA inhibitor activity, indicating that this priming 
effect of calcitriol requires expression of PKC. The calcium ionophore A23187 (0.1/~M) induced a 
modest increase in secreted PA inhibitor activity, in contrast to the secretion of PA activity which is 
consistently seen in response to calcitriol. Northern blot analysis demonstrated that A23187 induced an 
increase in PAI-2 mRNA and a marked reduction in uPA mRNA, while calcitriol induced opposite 
changes in both mRNA species. We conclude that calcitriol modulates uPA and PAI-2 expression by 
multiple mechanisms that are both PKC dependent and PKC independent. Our studies also demonstrated 
that increased intracellular calcium alters the synthesis of both uPA and PAI-2 in a manner which favors 
expression of PA inhibitor activity. 
There is considerable evidence to suggest that 
mononuclear phagocytes utilize plasminogen acti- 
vation in the pericellular environment to facilitate 
cellular migration and remodeling of extracellular 
matrix proteins [1, 2]. The mechanisms by which 
macrophages regulate plasminogen activation are 
complex, partly because these cells concurrently 
synthesize a urokinase-type plasminogen activator 
(uPA) and a specific plasminogen activator inhibitor, 
PAI-2 [3, 4]. We have demonstrated recently that 
uPA and PAI-2 can be modulated in an agonist- 
specific manner during in vitro differentiation of the 
human U937 monoblast-like cell line [3]. The effects 
of 1o:,25-dihydroxyvitamin D3 (calcitriol) are of 
particular interest because this agent concomitantly 
induces an increase in uPA synthesis and a marked 
reduction in PAI-2, resulting in expression of 
plasminogen activator (PA) rather than PA inhibitor 
activity in both conditioned media and cell lysates. 
Several lines of evidence suggest that calcitriol 
may induce macrophage differentiation at least 
partly by affecting signal transduction via protein 
kinase C (PKC) and altered concentrations of 
intracellular calcium. Both uPA and PAi~2 genes 
are induced by phorbol esters, which act principally 
by activating phospholipid-Ca2+-dependent PKC 
enzymes [3, 5]. Evidence derived largely from the 
phenotypically immature HL-60 line indicates that 
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calcitriol increases PKC expression during in vitro 
differentiation and that the differentiation process 
requires PKC activity [6, 7]. Calcitriol, like phorbol 
ester, can induce maturation of both HL-60 and 
U937 cells to a monocyte-macrophage phenotype 
[7, 8]. Calcitriol has also been shown to increase 
intracellular calcium in HL-60 cells and a variety of 
other cell types, and in some instances the effects of 
calcitriol on cellular differentiation and proliferation 
have been shown to be calcium dependent [9-11]. 
Finally, calcitriol primes macrophages to respond to 
other exogenous stimuli in a manner similar to the 
effects of interferon-3, [12-15]. Studies have clearly 
demonstrated that a cooperative interaction between 
increased intracellular calcium and PKC activation 
underlies the ability of interferon-3, to prime 
macrophages for tumor cytotox.i~ity [14, 15]. In an 
attempt to elucidate more fully th~ factors regulating 
the expression of uPA and PAI-2 activities 
by mononuclear phagocytes, we performed the 
following studies to determine the role of the Ca 2÷ 
and PKC signal transduction pathways in mediating 
the effects of calcitriol on uPA and PAI-2 synthesis. 
METHODS 
Reagents. Calcitriol (DuPhor Co., Amsterdam, 
Netherlands) was maintained as a 0.1 mM stock 
solution in ethanol at - 20  °. Calcitriol purity, 
concentration, and structural integrity were con- 
firmed by UV spectroscopy. Phorbol myristate 
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acetate (PMA; LC Services, Woburn, MA) was 
prepared from stock solutions of l mg/mL in 
dimethyl sulfoxide stored at -70  °. Plasminogen was 
prepared from outdated human plasma by lysine- 
Sepharose affinity chromatography (Pharmacia 
Chemicals, Piscataway, NJ) [16]. Plasmin con- 
taminating the plasminogen preparations was 
inactivated by treatment with phenylmethylsulfonyl 
fluoride (PMSF; 1 mM) for 16 hr at 25 °, followed by 
dialysis in 0.05 M phosphate buffer, pH7.5. The 
human PAI-2 cDNA used was the subcloned internal 
PstI-DraI fragment of the pcD-1214 clone (provided 
by Andrew C. Webb, Ph.D., Wellesley College) 
[17] in pGEM-2 inserted between the PstI and SmaI 
sites in the polylinker. Human urokinase cDNA was 
obtained from the Japanese Center Resources Bank- 
Gene, National Institute of Health, Tokyo [18]. This 
is a full-length clone inserted in the PstI-Pvu II site 
of a pBR322 vector. 
Cell culture. U937 cells (American Tissue Culture 
Collection, Rockville, MD) were cultured in medium 
consisting of RPMI-1640 (Hazleton, Denver, PA) 
supplemented with L-glutamine (2mM), penicillin 
(100 units/mL), streptomycin (100/~g/mL), genta- 
micin (100ktg/mL), and 5% fetal bovine serum 
(Hyclone, Logan, UT). Cells were cultured 
(2 × 105 mL) for 24 hr at 37 °, 5% CO2 in 75 cm 2 
flasks (Falcon Plastics, Oxnard, CA) prior to addition 
of calcitriol (50 nM), A23187 (0.1/~M), or diluent 
control (ethyl alcohol 0.05%). For most experiments, 
cells were then maintained in flasks for the indicated 
time periods. For measurement of PA and PA 
inhibitor activities, cells were washed and dispensed 
at 106 cells in l mL of serum-free medium 
supplemented with 0.1% human serum albumin 
(Transfusion Services, University of Michigan 
Medical Center) and cultured for 48 hr in sterile 
16mm polystyrene culture wells (Falcon). Cell 
counts were performed with a hemocytometer and 
viability was confirmed by trypan blue exclusion. 
Preliminary experiments confirmed that after 48 hr 
in serum-free medium, the cell number did not 
increase significantly. Further, there were no 
significant differences between experimental con- 
ditions in either the number or viability of cells after 
the 48-hr ctdture period (data not shown). 
Phorbol ester binding. Cells were collected by 
centrifugation, washed twice in phosphate-buffered 
saline, pH 7.4, and sonicated in 500/~L of Buffer A 
(Tris, 25mM; sucrose, 250mM; dithiothreitol, 
0.5mM; EDTA, 2raM; ethyleneglycolbis(amino- 
ethylether)tetra-acetate (EGTA), 10 mM; mag- 
nesium acetate, lmM;  PMSF, 2mM; leupeptin, 
50 ~ug/mL, pH 7.4). The sonicates were centrifuged 
at 12,000 g for 20 min at 4 °. The supernatant (cytosol) 
fraction was then collected. The pellet (membrane) 
fraction was washed with 200/~L Buffer A, and the 
wash was pooled with the supernatant fraction. 
Protein concentrations of cytosol and membrane 
fractions (in Buffer A) were measured by the method 
of Bradford [19] using bovine ]/-globulin as a 
standard. To measure [3H]phorbol dibutyrate 
([3H]PDBu) binding, cytosol or membrane (200/zg/ 
mL protein) was incubated with [3H]PDBu (80 nM; 
Amersham, Arlington Heights, IL) in Buffer B 
(Tris, 50 mM, pH 7.6; phosphatidylserine 100/zg/ 
mL; CaC12, 2 mM; bovine ~,-globulin, 2 mg/mL) for 
30 min at 37 °. The binding reaction was terminated 
by precipitating proteins with 35% polyethylene 
glycol and the sample were centrifuged at 12,000 g, 
4 ° for 20 min. The pellet was washed once with 35% 
polyethylene glycol, and the centrifugation step was 
repeated. The tip of the tube containing the pellet 
was amputated and placed in Ecolyte aqueous 
scintillation fluid (ICN Chemicals, Irvine, CA) and 
counted in a Beckman LS 1801 scintillation 
counter (Beckman Instruments, Irvine, CA). Specific 
[3H]PDBu binding was calculated as total [3H]PDBu 
bound less the nonspecific binding measured in 
parallel samples also. containing unlabeled PDBu 
(80/uM). Under all conditions, nonspecific binding 
did not exceed 30% of the total. 
Esterolytic assay for PA and PA inhibitor activities. 
Plasminogen activator activity was measured with 
the esterolytic assay of Coleman and Green, with 
minor adaptations for use in 96-well plates [20]. 
Conditioned media (10/~L) were mixed with an 
optimal amount of plasminogen in 0.67 M glycine/ 
0.17% bovine serum albumin (BSA)/1.7/~M Tris/ 
0.02% Triton X-100 (50ktL) and incubated at 37 ° 
for 60 min. Plasmin generated during this step was 
quantified by the addition of a plasmin substrate, 
thiobenzyl benzyloxycarbonyl-L-lysinate (0.2 mM; 
Calbiochem, La Jolla, CA), and 5,5'-dithiobis-2- 
nitrobenzoic acid (2.2 raM; Catbiochem) in 200/uL 
of 0.2 M phosphate/0.2 M NaC1/1% Triton X-100. 
After 30-60 rain at 37 °, optical absorbance was read 
at 414nm with a Titertek Plus multichannel 
spectrophotometer (Flow Laboratories, McLean, 
VA). PA activity was determined from a standard 
curve generated with commercially prepared uro- 
kinase (Calbiochem), and expressed in milliPloug 
units (mPU). As this assay relies on the conversion 
of plasminogen to plasmin, prourokinase could not 
be distinguished from active urokinase by this 
method [4]. To measure PA inhibitor activity, serial 
dilutions of the test samples were co-incubated with 
2 mPU of commercial urokinase, and the residual 
PA activity was measured in standard fashion. PA 
inhibitor activity was calculated from a plot of the 
sample concentration (reciprocal of the dilution 
factor) versus residual PA activity, and expressed in 
PAI units/mL (1 PAI unit = 1 mPU PA inhibited). 
mRNA analysis. For these experiments, U937 
cells were cultured for 4 hr with A23187 (0.1/~M), 
calcitriol (50 nM) for 24 hr, or ethyl alcohol (0.05%) 
for 24 hr. Cells were dislodged by gentle scraping, 
washed with RPMI, and flash frozen for storage at 
-70  °. To extract cellular RNA, cell pellets were 
sonicated on ice in urea (5 M), LiC1 (3 M), and 
heparin (14 units/mL) [21]. RNA was pelleted after 
overnight precipitation at -20  ° and extracted 
repeatedly with phenol/chloroform. The aqueous 
layer was precipitated with ethanol/sodium acetate 
at -20  °. The RNA pellet was suspended in RNAase- 
free water and concentration determined by 
spectroscopy at 260nm. The RNA was size 
fractionated electrophoretically on 1% agarose gels 
(10/zg/lane) containing 0.22 M formaldehyde and 
0.4/~g/mL ethidium bromide [22]. Visualization of 
ribosomal bands under UV light provided internal 
size markers for each lane and also confirmed that 
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Table 1. Effects of calcitriol on expression of protein kinase 
C by U937 cells 
Treatment with Specific binding of 
50 nM Calcitriol [3H]PDBu 
(hr) (% control) 
6 88.4 ___ 12.2" 
12 96.7 --- 4.93 
24 122.2 --- 8.05"~ 
48 110 --_ 19.5 
72 109.3 --- 14.6 
* Mean - SEM, N = 3-7 Experiments. 
~" P < 0.05 compared to unstimulated control. 
~ Binding of unstimulated control cells at 24 hr was 
3382 +--424 fmol/mg protein. The increase with calcitriol 
stimulation was 857 - 309 fmol/mg protein (P < 0.05). 
the RNA content was equal among corresponding 
lanes on the gels. The RNA was transferred to 
Hybond nylon filters (Amersham) and fixed by 
exposure to UV light [22]. The cDNA clone of 
interest was labeled with [32p]dCTP (Amersham) by 
random priming, achieving specific activities of 
approximately 5 × 108 cpm/#g DNA [23]. The nylon 
filters were then hybridized with 2 × 107 cpm of 
[32p]cDNA for 18 hr at 65 °, followed by serial washes 
of increasing stringency, with the final wash consisting 
of 1.5 mM sodium citrate, 15 mM sodium chloride, 
0.1% sodium dodecyl sulfate, 1 mM EDTA, 10 mM 
sodium phosphate at 68 ° [20]. The filters were then 
developed by autoradiography using Kodak XAR-5 
X-Omat AR film at - 7 0  °, and scanned by laser 
densitometry (LKB Ultroscan XL, Piscataway, N J). 
Statistics. Where appropriate, comparisons of 
group means were performed with an unpaired, two- 
tailed Student's t-test [24]. 
RESULTS 
Effects o f  calcitriol on protein kinase C. To 
determine if calcitrioi alters cellular expression of 
PKC, U937 cells were cultured with or without 
calcitriol (50 nM) for periods up to 72 hr and the 
cellular content of PKC was assessed by specific 
binding of [3H]PDBu. As shown in Table 1, binding 
of [3H]PDBu was unaffected by stimulation with 
calcitriol for 6 and 12hr. After 24hr, calcitriol 
induced a modest increase in [3H]PDBu binding, 
reaching 122.2 +- 8.0% of control values (P < 0.05). 
This corresponded to an absolute increase in binding 
of 857 --- 309 fmol/mg protein (P < 0.05). This effect 
was negated by co-stimulation with cycloheximide 
(5 #g/mL), indicating a requirement for protein 
synthesis (not shown). After incubation with calcitriol 
for 48 and 72 hr, [3H]PDBu binding was diminished 
and indistinguishable from that of control cells. The 
increase in [3H]PDBu binding at 24 hr was evaluated 
by Scatchard analysis, demonstrating that calcitriol 
treatment had no effect on binding affinity (Kd), but 
induced an increase in Bmax comparable to the above 
increase in [3H]PDBu binding (not shown). 
To determine if PKC activity is necessary for 
calcitriol to induce secretion of PA activity, cells 
were incubated for 48 hr in the presence or absence 
of calcitriol (50 nM) or staurosporine, a potent PKC 
inhibitor (2nM; Kamiya Biomedical, Thousand 
Oaks, CA). At the concentration used, staurosporine 
has been shown to express excellent specificity for 
PKC [25], and had no adverse effects on cell viability 
(not shown). After this incubation period, the cells 
were washed and incubated in serum-free medium 
for 48 hr, as described in Methods. As shown in Fig. 
1, unstimulated U937 cells secreted PA inhibitor 
activity. Calcitriol induced the cells to express PA 
activity rather than PA inhibitor. As we have shown 
previously [3], PA activity was below the detection 
limits of the assay under conditions where PA 
inhibitor activity was demonstrable; likewise, PA 
inhibitor activity was not demonstrable in conditioned 
media containing detectable PA activity (calcitriol 
and calcitriol + staurosporine). Staurosporine had 
no effect on PA inhibitor secretion by otherwise 
unstimulated cells, and likewise had no effect on 
calcitriol-induced PA secretion, indicating that 
optimal expression of PKC activity was not required 
for the observed effects of calcitriol. We have shown 
that pretreatment with calcitriol amplifies secretion 
of PAI-2 by U937 cells in response to phorbol 
myristate acetate [3]. Since the principal action of 
PMA is to activate PKC, separate experiments were 
performed to determine if PKC activity was required 
for this priming effect of calcitriol. Cells were 
incubated with calcitriol in the presence or 
absence of staurosporine, washed extensively, and 
subsequently incubated for 24hr in serum-free 
medium containing an optimally stimulating con- 
centration of PMA (10ng/mL). Staurosporine 
substantially reduced the resultant secreted PA 
inhibitor activity to 43% of control values (P < 0.05; 
Fig. 1). Carry-over of staurosporine into the 
incubation with PMA was not responsible for this 
effect, as pretreatment with staurosporine alone had 
no effect on PMA-induced PA inhibitor activity. 
This indicates that, in contrast to the effect of 
calcitriol alone, this priming effect of calcitriol 
requires PKC activity. PA activity was not 
demonstrable in any of the PMA-treated cells, likely 
due to the augmented secretion of PA inhibitor 
activity [3]. 
Effects o f  calcitriol and A23187 on secreted PA 
and PA inhibitor activities. Experiments were 
performed to determine if the effects of calcitriol on 
secreted PA and PA inhibitor activities could be 
duplicated by the calcium ionophore A23187. U937 
cells were suspended in serum-free medium in the 
presence or absence of A23187 (0.5gM). For 
comparison, cells pretreated for 24 hr with calcitriol 
(50nM) were cultured in parallel. After 48hr,  
conditioned media were collected and assayed for 
PA and PA inhibitor activities. As shown in Fig. 2, 
calcitriol and A23187 induced opposite changes in 
secreted activity. In contrast to the effect of calcitriol, 
A23187 induced a modest increase in secreted PA 
inhibitor activity, and a conversion from PA inhibitor 
to PA secretion was never observed in these cells. 
In preliminary studies, treatment with A23187 (0.01 
to 1.0 #M) or ionomycin (5/~M) for periods up to 
24 hr produced similar results (not shown). As in 
our previous study [3], the PA and PA inhibitor 
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Fig. 1. Effect of staurosporine on calcitriol-induced modulation of U937 cell PA and PA inhibitor 
activities. U937 cells were pretreated with 50 nM calcitriol with or without 2 nM staurosporine, a protein 
kinase C inhibitor. Cells were subsequently cultured in serum-free medium and assayed for secreted 
PA and PA inhibitor activities as described in Methods (mean -+ SEM, N = 5). Data are expressed in 
milliPloug units (mPU) and PAI units (1 PAI unit = 1 mPU PA inhibited). Cells were also stimulated 
with 10ng/mL phorbol myfistate acetate (PMA) during the second incubation period. Key: (*) 
pretreatment with staurosporine significantly (P < 0.05) reduced the PMA-induced secretion of PA 
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Fig. 2. Effects of calcitriol (D3) and A23187 on secretion 
of PA and PA inhibitor activities. Cells were pretreated 
with calcitriol (50 nM) and cultured in serum-free medium 
for 48 hr to determine secretion of PA and PA inhibitor 
activities, as described in Methods. For comparison, cells 
were stimulated with the calcium ionophore A23187 
(0.5/~M) during the 48-hr incubation period. A23187 
induced a modest increase in PA inhibitor activity which 
did not reach statistical significance relative to control cells 
(P = 0.2). Data are expressed as in Fig. 1. 
activities of cell lysates paralleled the conditioned 
media under all t reatment conditions (not shown). 
Northern blot analysis. To expand on the 
comparison of the effects of calcitriol and A23187 
on regulation of PA and PA inhibitor activities, 
Northern analysis was performed to determine the 
effects on the biosynthesis of the individual uPA and 
PAI-2 proteins. Cells were cultured in serum- 
supplemented medium alone, or treated with 
calcitriol (50 nM) for 48 hr or A23187 (0.5/~M) for 
4 hr. Steady-state levels of m R N A  for uPA and PAI- 
2 were then determined as described in Methods. 
Using control cells as a reference, calcitriol and 
A23187 induced opposite changes in steady-state 
levels of mRNA for PAI-2; calcitriol consistently 
caused a marked reduction in PAI-2 mRNA,  in 
contrast to an increase in message level induced by 
A23187 (Fig. 3). Calcitriol and A23187 also produced 
opposite changes in uPA mRNA. However, in this 
instance, calcitriol induced an increase in uPA 
mRNA, whereas A23187 decreased the level of uPA 
mRNA. Therefore, calcitriol and A23187 share an 
interesting property, in that they induce opposite 
directional changes in mRNA levels for uPA and 
PAI-2 and, in both cases, the relative changes in 
uPA and PAI-2 mRNA parallel the eventual 
secretion of PA or PA inhibitor activities. However,  
the effects of calcitriol were opposite to those of 
A23187 for both uPA and PAI-2 expression, 
effectively arguing that an increase in intracellular 
calcium is not the proximate mechanism by which 
calcitriol modulates uPA and PAI-2 expression. 
DISCUSSION 
Local formation of plasmin at inflammatory foci 
is thought to contribute to proteolytic release of 
proinflammatory peptides, release and activation of 
cytokines, and degradation of extravascular fibrin 
and extracellular matrix glycoproteins [2, 26-29]. 
While the formation and inactivation of extravascular 
plasmin are undoubtedly a complex multistep 
process, mononuclear phagocytes provide a central 
regulatory role in plasminogen activation by 
synthesizing and secreting uPA and PAI-2 [3, 4]. 
Secreted PAI-2 may not only prevent excessive 
plasmin formation, but also assist in spatially 
restricting this process to the pericellular environment 
where uPA is localized to plasma membrane 
receptors and is relatively resistant to inhibitors of 
PA or plasmin [30]. It is therefore of considerable 
interest to define the pathways by which expression 
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Fig. 3. Northern blot analysis of calcitriol (D3) and A23187-treated cells. Cells were treated with 
calcitriol or A23187 as described in Methods. The top panel shows mRNA levels for PAI-2 (major 
band at 2 kb). Densitometry measurements of the Northern blot are shown at the right, with optical 
density expressed in arbitrary units, normalized to control cells. The Northern blot for uPA is shown 
in the lower panel (major band at 2.4 kb). Results are expressed as in the upper panel. Ethidium 
bromide-stained ribosomal RNA bands are shown in the insert at the right to demonstrate equal RNA 
loading of the lanes. 
of uPA and PAI-2 activities by macrophages are 
coordinately regulated. 
A host of exogenous signals have been shown to 
stimulate expression of PA activity by macrophages 
in vitro, leading to common use of elevated PA 
activity as a functional marker of macrophage 
activation [31, 32]. Previous studies have shown that 
stimulation with phorbol ester is sufficient to increase 
expression of both uPA and PAI-2, presumably by 
activating PKC [3, 5]. Bacterial lipopolysaccharide 
causes similar increases in uPA and PAI-2 synthesis 
and secretion [30, 33]. PKC activation may be 
responsible for this effect as well, as lipo- 
polysaccharide and phorbol ester produce similar 
patterns of protein phosphorylation in macrophages, 
suggesting overlapping mechanisms of action [34]. 
The signal transduction pathways mediating 
expression of uPA and PAI-2 are otherwise 
incompletely defined, although agents which augment 
levels of cyclic AMP generally suppress expression 
of PA activity [35, 36]. However, these studies 
largely relied on measurement of plasminogen- 
dependent proteolysis, and therefore .were incapable 
of distinguishing whether changes in PA activity 
resulted from changes in expression of PA or PA 
inhibitor proteins. Using both enzymatic assays and 
measurements of specific mRNA species, we have 
shown recently that calcitriol can augment uPA 
synthesis while concomitantly reducing synthesis of 
PAI-2 [3]. These changes in synthetic activity 
paralleled the ultimate expression of protease/ 
inhibitor activity in cell lysates and medium. The 
ability of macrophages to regulate uPA and PAI-2 
gene expression in either parallel or inverse fashion 
indicates a means by which these ceils can selectively 
promote or suppress plasminogen activation. More- 
over, this type of interplay between proteases and 
antiproteases may not be unique to PA activity, as 
similar regulation in tandem or inverse fashion has 
been shown for collagenase and the tissue inhibitor 
of metalloproteases (TIMP) [37, 38]. Therefore we 
have sought to characterize more fully mechanisms by 
which uPA and PAI-2 can regulated independently. 
Experiments were first performed to examine the 
possibility that calcitriol modulated uPA and PAI-2 
expression at least partly by inducing changes in 
cellular PKC activity. In our previous study, calcitriol 
amplified phorbol-induced expression of both uPA 
and PAI-2 [3]. Calcitriol-induced differentiation of 
HL-60 promyelocytes into a macrophage phenotype 
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is PKC dependent and is associated with an increase 
in cellular PKC activity [6, 7]. These observations 
further support the possibility that calcitriol alters 
expression of phorbol inducible genes by amplifying 
the PKC signal transduction pathway. Contrary to 
this argument, there is limited evidence that 
amplification of PKC activity is not required for 
induction of cell differentiation [39, 40]. We therefore 
questioned whether calcitriol altered cellular PKC 
activity under conditions known to modulate 
expression of uPA and PAI-2 proteins. Calcitriol 
induced an increase in cytosolic [3H]PDBu binding 
of 22% over control values. This effect was transient 
and seen after a 24-hr incubation. Importantly, the 
primary modulation of uPA and PAI-2 synthesis 
was PKC independent,  as co-incubation with 
staurosporine had no effect on this direct effect of 
calcitriol. However,  the ability of calcitriol to prime 
cells for PMA-induced PAI-2 synthesis was clearly 
suppressed by staurosporine and, therefore, at least 
partly PKC dependent.  
Calcitriol-induced differentiation of HL-60 pro- 
myelocytes is associated with an increase in 
intracellular calcium concentration, and calcium is 
required for some effects of calcitriol on cellular 
differentiation [9-11]. In view of the known synergy 
between calcium inophores and PKC activation in 
macrophage priming [14, 15], we reasoned that 
calcitriol may modulate uPA and PAI-2 expression 
by a primary effect on intracellular calcium, and 
therefore compared the effects of calcitriol and the 
calcium ionophore A23187. A23187 shared with 
calcitriol the capacity to induce opposite changes in 
uPA and PAI-2 m R N A  (Fig. 3). However,  the 
effects were the inverse of those seen with calcitriol, 
as A23187 decreased uPA mRNA while increasing 
PAI-2 mRNA. With both stimuli, the comparative 
changes in the two mRNA species were consistent 
with the ultimate expression of PA or PA inhibitor 
activity (Fig. 2). Several important conclusions may 
be drawn from these results. First, inverse regulation 
of uPA and PAI-2 is not unique to calcitriolo Because 
altered intracellular calcium is a common event in 
signal transduction, its occurrence may mediate or 
influence the effects of many exogeneous stimuli on 
uPA and PAI-2 expression. Second, depending on 
the agonist used, the inverse regulation of uPA and 
PAI-2 can favor either augmented or suppressed 
expression of PA activity, potentially expanding the 
range over which macrophages can direct local 
plasminogen activation. Finally, it is clear that 
caicitriol does not affect uPA and PAI-2 expression 
by increasing intracellular calcium. Interestingly, we 
previously showed that exogenous calcium and 
calcitriolcan have opposite effects on the proliferation 
of malignant cells [10]. Further studies will be 
necessary to determine if calcitriol may be 
antagonizing some effects of intracellular calcium. 
In addition, the presence of a calcitriol receptor in 
U937 cells raises the possibility that the hormone 
directly affects gene expression in the manner 
demonstrated for other steroid hormones [41]. 
In summary, we have demonstrated that calcitriol 
alters synthesis of uPA and PAI-2 by both PKC- 
dependent and PKC-independent pathways in U937 
cells. Also, elevated intracellular calcium caused an 
increase in PAI-2 mRNA with a coincident reduction 
in uPA mRNA and ultimately, enhanced expression 
of PA inhibitor activity. Changes in intracellular 
calcium, therefore, may be an important signal in 
determining the expression of uPA and PAI-2 by 
macrophages in response to a variety of stimuli, and 
calcitriol may act to oppose this effect of calcium. 
Further characterization of the signal transduction 
pathways that influence comparative expression of 
the uPA and PAI-2 genes will be instrumental in 
understanding the basis for agonist-specific and 
differentiation-associated expression of macrophage 
protease and antiprotease activities. 
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